The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Mediaplanet today announces the launch of its latest Digestive Health campaign, distributed nationwide within USA TODAY and ...

Colon and rectal cancer can feel silent until it suddenly is not. A new Finnish study suggests that, for many patients, ...

As of July 1, Ontario will offer publicly funded colorectal cancer (CRC) screening to patients as young as 45 years. Patients ...